News

14

Oct2016

Trevi Therapeutics Announces Positive Results from Phase 2 Trial in Prurigo Nodularis

NEW HAVEN, CT, USA I October 13, 2016 I Trevi Therapeutics, Inc. (“Trevi” or the “Company”), a late-stage ... Read More

13

Sep2016

ChemDiv is presenting at the SCI’s event: Innovation in Design, Supply and Acquisition for Compound Screening Libraries, on 14th September 2016 in Hatfield, UK

‪Dr. Volodymyr Kysil will present on "ChemDiv’s Special and Focused Libraries". Libraries of sp3-enriched fragments, β-turn and α-helix-mimetics, ... Read More

08

Sep2016

ChemDiv and Insilico Medicine Form A Strategic Alliance to Develop Oncology Focused Libraries Using Artificial Intelligence

ChemDiv, Inc. and Insilico Medicine, Inc. announced the signing of a collaboration agreement aimed at partnering to develop and market ... Read More

22

Jun2016

A Subsidiary of Rostec Corporation and HTC ChemRar Launch a Joint Venture for Development and Manufacturing of the Next Generation of Antivirals in Russia and the Eurasian Economic Union

SAN DIEGO, CA, June 22, 2016 - National Immunobiological Company (Rostec State Corporation) and ChemRar Pharma (ChemRar HTC) announced the ... Read More

Send a message

Request a call